UnitedHealth Group Incorporated $UNH Shares Sold by Elk River Wealth Management LLC

Key Points

• Elk River Wealth Management LLC sold 13,158 shares of UnitedHealth Group, reducing its holdings by 77.6% to 3,804 shares, valued at $1,187,000.
• Several large investors made significant adjustments to their positions in UnitedHealth Group, with GAMMA Investing LLC increasing its stake by over 56,000% in the first quarter.
• Analysts have mixed views on UnitedHealth Group, with new price targets ranging from $310 to $395, while the average rating is a "Moderate Buy."

Elk River Wealth Management LLC trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 77.6% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,804 shares of the healthcare conglomerate's stock after selling 13,158 shares during the quarter. Elk River Wealth Management LLC's holdings in UnitedHealth Group were worth $1,187,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently bought and sold shares of UNH. Bayforest Capital Ltd raised its holdings in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after acquiring an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd raised its holdings in UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after acquiring an additional 50 shares during the period. Copia Wealth Management bought a new stake in UnitedHealth Group during the fourth quarter valued at about $42,000. IAG Wealth Partners LLC bought a new stake in shares of UnitedHealth Group in the first quarter worth about $42,000. Finally, Investment Management Corp VA ADV purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth about $44,000. 87.86% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the company. Baird R W downgraded UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research report on Thursday, July 31st. Oppenheimer decreased their target price on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 30th. KeyCorp dropped their price target on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research report on Wednesday, July 30th. Cantor Fitzgerald reiterated an "overweight" rating and issued a $440.00 price target on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Finally, UBS Group reiterated a "buy" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and an average price target of $358.95.

UnitedHealth Group Trading Up 0.6%

Shares of UnitedHealth Group stock traded up $1.90 on Friday, hitting $336.72. 13,528,738 shares of the company traded hands, compared to its average volume of 13,748,202. The stock's 50 day moving average price is $295.67 and its 200-day moving average price is $365.19. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a market cap of $304.96 billion, a PE ratio of 14.59, a PEG ratio of 2.19 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business's revenue was up 12.9% on a year-over-year basis. During the same period in the prior year, the firm posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. The ex-dividend date is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. UnitedHealth Group's dividend payout ratio is currently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.